@bobsee @the buck
Spot on. The amount of knee arthroscopies or "clean outs" prior to eventual TKRs that go on in private land in Australia is crazy, I can only imagine in the USA it is the same but worse. Whilst not a threat to getting approval, I also think the effect of weight loss drugs on PARs addressable market has been ignored.
Anyhow for whatever reason I have a renewed sense of optimism this week. The funding situation forever baffles me and will continue to do so, but I just can't see that provided we get 2mg twice weekly approval, this doesn't get through to a NDA one way or another.
research reports and media, page-4345
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $80.45M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 24.0¢ | 23.0¢ | $39.25K | 166.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 198917 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 24012 | 7 |
View Market Depth
| Last trade - 11.00am 05/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |